Geriatric Oncology Articles Archives - Page 33 of 36

Randomized Phase III Trial Comparing Weekly Docetaxel Plus Cisplatin Versus Docetaxel Monotherapy Every 3 Weeks in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Intergroup Trial JCOG0803/WJOG4307L

Lina Silva Salinas2021-07-29T22:38:05+02:00

Abe T, Takeda K, Ohe Y, Kudoh S, Ichinose Y, Okamoto H, Yamamoto N, Yoshioka H, Minato K, Sawa T, Iwamoto Y, Saka H, Mizusawa J, Shibata T, Nakamura S2, Ando M, Yokoyama A, Nakagawa K, Saijo N, Tamura T. J Clin Oncol. 2015 Feb 20;33(6):575-81. doi: 10.1200/JCO.2014.55.8627. Epub 2015 Jan 12. (Pubmed)

Randomized Phase III Trial Comparing Weekly Docetaxel Plus Cisplatin Versus Docetaxel Monotherapy Every 3 Weeks in Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Intergroup Trial JCOG0803/WJOG4307LLina Silva Salinas2021-07-29T22:38:05+02:00

Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.

Lina Silva Salinas2021-07-29T22:38:05+02:00

Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K. J Clin Oncol. 2015 Mar 1;33(7):716-22. doi: 10.1200/JCO.2014.57.2743. Epub 2015 Jan 5. (Pubmed)

Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer.Lina Silva Salinas2021-07-29T22:38:05+02:00

Can older women with early breast cancer avoid radiation?

Lina Silva Salinas2021-07-29T22:38:05+02:00

Hughes KS, Schnaper LA. Lancet Oncol. 2015 Mar;16(3):235-7. doi: 10.1016/S1470-2045(15)70014-8. Epub 2015 Jan 28. (The Lancet Oncology)

Can older women with early breast cancer avoid radiation?Lina Silva Salinas2021-07-29T22:38:05+02:00

Expert consensus panel guidelines on geriatric assessment in oncology

Lina Silva Salinas2021-07-29T22:38:05+02:00

O'Donovan A, Mohile SG, Leech M. Eur J Cancer Care (Engl). 2015 Jul;24(4):574-89. doi: 10.1111/ecc.12302. Epub 2015 Mar 11. (Pubmed)

Expert consensus panel guidelines on geriatric assessment in oncologyLina Silva Salinas2021-07-29T22:38:05+02:00

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)

Lina Silva Salinas2021-07-29T22:38:05+02:00

Lamont EB, Schilsky RL, He Y, Muss H, Cohen HJ, Hurria A, Meilleur A, Kindler HL, Venook A, Lilenbaum R, Niell H, Goldberg RM, Joffe S; Alliance for Clinical Trials in Oncology. J Natl Cancer Inst. 2014 Nov 27;107(1):336. doi: 10.1093/jnci/dju336. Print 2015 Jan. (Pubmed)

Generalizability of trial results to elderly Medicare patients with advanced solid tumors (Alliance 70802)Lina Silva Salinas2021-07-29T22:38:05+02:00

Minimize toxicity or preserve efficacy? A delicate trade-off in the management of older patients with lung cancer

Lina Silva Salinas2021-07-29T22:38:05+02:00

Owonikoko TK, Ramalingam SS. J Clin Oncol. 2015 Feb 20;33(6):534-6. doi: 10.1200/JCO.2014.59.5033. Epub 2015 Jan 12. (Journal of Clinical Oncology)

Minimize toxicity or preserve efficacy? A delicate trade-off in the management of older patients with lung cancerLina Silva Salinas2021-07-29T22:38:05+02:00

Tumor marker usage and medical care costs among older early-stage breast cancer survivors

Lina Silva Salinas2021-07-29T22:38:05+02:00

Ramsey SD, Henry NL, Gralow JR, Mirick DK, Barlow W, Etzioni R, Mummy D, Thariani R, Veenstra DL. J Clin Oncol. 2015 Jan 10;33(2):149-55. doi: 10.1200/JCO.2014.55.5409. Epub 2014 Oct 20. (Pubmed)

Tumor marker usage and medical care costs among older early-stage breast cancer survivorsLina Silva Salinas2021-07-29T22:38:05+02:00

Polypharmacy: Geriatric Oncology Evaluation Should Become Mainstream

Lina Silva Salinas2021-07-29T22:38:05+02:00

Lichtman SM. J Clin Oncol. 2015 Mar 23. pii: JCO.2014.60.3548. [Epub ahead of print] (Journal of Clinical Oncology)

Polypharmacy: Geriatric Oncology Evaluation Should Become MainstreamLina Silva Salinas2021-07-29T22:38:05+02:00

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?

Lina Silva Salinas2021-07-29T22:38:06+02:00

Shumway DA, Hamstra DA. J Clin Oncol. 2015 Mar 1;33(7):676-8. doi: 10.1200/JCO.2014.59.4093. Epub 2015 Jan 5. (Journal of Clinical Oncology)

Ageism in the undertreatment of high-risk prostate cancer: how long will clinical practice patterns resist the weight of evidence?Lina Silva Salinas2021-07-29T22:38:06+02:00

Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.

Lina Silva Salinas2021-07-29T22:38:06+02:00

Ostronoff F, Othus M, Lazenby M, Estey E, Appelbaum FR, Evans A, Godwin J, Gilkes A, Kopecky KJ, Burnett A, List AF, Fang M, Oehler VG, Petersdorf SH, Pogosova-Agadjanyan EL, Radich JP, Willman CL, Meshinchi S, Stirewalt DL. J Clin Oncol. 2015 Apr 1;33(10):1157-64. doi: 10.1200/JCO.2014.58.0571. Epub 2015 Feb 23. (Pubmed)

Prognostic Significance of NPM1 Mutations in the Absence of FLT3-Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report.Lina Silva Salinas2021-07-29T22:38:06+02:00

Geriatric Oncology Articles

SIOG Head Office

ECOSOC Special

Quick links

Stay in the loop with SIOG’s newsletter!

Geriatric Oncology Articles

Stay in touch and share our news!

SIOG Head Office

ECOSOC Special

Quick links

Stay in the loop with SIOG’s newsletter!